Santhera Pharmaceuticals Holdings AG (SANN.S)
27.00CHF
10:32am EST
CHF0.00 (+0.00%)
CHF27.00
CHF26.80
CHF27.00
CHF26.75
1,475
1,806
CHF52.40
CHF23.50
About
Overall
| Beta: | 0.35 |
| Market Cap (Mil.): | CHF95.11 |
| Shares Outstanding (Mil.): | 3.52 |
| Annual Dividend: | -- |
| Yield (%): | -- |
Financials
| SANN.S | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 6.61 | 4.67 |
| EPS (TTM): | -29.72 | -- | -- |
| ROI: | -45.86 | 6.11 | 2.82 |
| ROE: | -46.01 | 9.13 | 3.52 |
WRAPUP 1-Addex drug flop deals blow to European biotech
* Elan, Transition hit by Alzheimer's drug setback (Adds analyst and company comment, industry detail)
UPDATE 2-Addex stops development of lead drug
(Rewrites throughout with stopping development of lead drug)
UPDATE 1-Addex stops lead drug trial due to liver problems
* Addex trying to understand between liver problems and drug
Swiss stocks - Factors to watch on Dec 9
ZURICH, Dec 9 (Reuters) - The following are some of the main factors expected to affect Swiss stocks on Wednesday:
Swiss stocks - Factors to watch on Dec 8
ZURICH, Dec 8 (Reuters) - The following are some of the main factors expected to affect Swiss stocks on Tuesday:
UPDATE 1-Addex lead drug hits target in mid-stage study
* Addex says sees further development in ADX10059 study
UPDATE 3-Biovail profit dips but hunt for deals continues
* Shares off 1.3 percent at C$13.95 (Adds analyst and company quotes. In U.S. dollars)
UPDATE 3-Cytos anti-smoking vaccine flops; shares drop
(Rewrites, adds more comment, detail and updated shares)
Swiss stocks - Factors to watch on Oct 5
ZURICH, Oct 5 (Reuters) - Swiss shares were expected to edge higher on Monday as European markets were seen rebounding from a four-week closing low.
Swiss stocks - Factors to watch on Sept 4
ZURICH, Sept 4 (Reuters) - Swiss shares were seen opening slightly firmer after U.S. retail sales data boosted U.S. and Asian markets although there was caution ahead of a U.S. payrolls report.





Earnings vs
Estimates